WallStreetZenWallStreetZen

NASDAQ: BIVI
Biovie Inc Stock Forecast, Predictions & Price Target

Analyst price target for BIVI

Based on 1 analyst offering 12 month price targets for Biovie Inc.
Min Forecast
$5.00+836.33%
Avg Forecast
$5.00+836.33%
Max Forecast
$5.00+836.33%

Should I buy or sell BIVI stock?

Based on 1 analyst offering ratings for Biovie Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BIVI stock forecasts and price targets.

BIVI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-30

1 of 1

Forecast return on equity

Is BIVI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is BIVI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BIVI revenue forecast

What is BIVI's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.8M

BIVI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BIVI$0.53$5.00+836.33%Buy
INDP$2.49N/AN/A
GLTO$0.78N/AN/A
NRBO$4.34N/AN/A
NRSN$1.73N/AN/A

Biovie Stock Forecast FAQ

Is Biovie Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BIVI) stock is to Buy BIVI stock.

Out of 1 analyst, 0 (0%) are recommending BIVI as a Strong Buy, 1 (100%) are recommending BIVI as a Buy, 0 (0%) are recommending BIVI as a Hold, 0 (0%) are recommending BIVI as a Sell, and 0 (0%) are recommending BIVI as a Strong Sell.

If you're new to stock investing, here's how to buy Biovie stock.

What is BIVI's revenue growth forecast for 2026-2026?

(NASDAQ: BIVI) Biovie's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Biovie's revenue in 2024 is $0.

In 2026, BIVI is forecast to generate $510,350,054 in revenue, with the lowest revenue forecast at $510,350,054 and the highest revenue forecast at $510,350,054.

What is BIVI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BIVI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BIVI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BIVI price target, the average BIVI price target is $5.00, with the highest BIVI stock price forecast at $5.00 and the lowest BIVI stock price forecast at $5.00.

The Wall Street analyst predicted that Biovie's share price could reach $5.00 by Nov 30, 2024. The average Biovie stock price prediction forecasts a potential upside of 836.33% from the current BIVI share price of $0.53.

What is BIVI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BIVI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.